RALGAPA1 and breast cancer: Decreased expression of RALGAPA1, the catalytic subunit of RALGAP1 revealed its decreased expression is associated with worse outcome in BC patients (Supplemental Figure S8A) while expression of RALGAP2, the catalytic subunit of RALGAP2 revealed it is not prognostic of outcome (Supplemental Figure S8B).